We are live on ! Find out more
KCM

Knoll Capital Management Portfolio holdings

AUM $180M
1-Year Est. Return 66.11%
This Fund
S&P 500
This Quarter Est. Return
-9.28%
1 Year Est. Return
+66.11%
3 Year Est. Return
+268.55%
5 Year Est. Return
+741%
10 Year Est. Return
+10,877.35%
AUM
$159M
AUM Growth
-$22.6M
Cap. Flow
+$44.4K
Cap. Flow %
0.03%
Top 10 Hldgs %
87.32%
Holding
43
New
5
Increased
6
Reduced
3
Closed
2

Top Buys

Rank Stock Value
1
AVXL icon
Anavex Life Sciences
AVXL
+$2.59M
2
SPRO icon
Spero Therapeutics
SPRO
+$717K
3
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
+$511K
4
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$499K
5
AEM icon
Agnico Eagle Mines
AEM
+$460K

Top Sells

Rank Stock Value
1
BX icon
Blackstone
BX
+$976K
2
AMD icon
Advanced Micro Devices
AMD
+$495K
3
KL
Kirkland Lake Gold Ltd Ordinary
KL
+$451K
4
SNGX icon
Soligenix
SNGX
+$111K

Sector Composition

Rank Sector Weight
1 Healthcare 86.23%
2 Materials 3.35%
3 Technology 2.92%
4 Financials 1.93%
5 Industrials 1.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SA
26
Seabridge Gold
SA
$3.35B
$592K 0.37%
32,000
– –
MMX
27
DELISTED
Maverix Metals Inc. Common Shares
MMX
$552K 0.35%
115,000
– –
PAAS icon
28
Pan American Silver
PAAS
$21.6B
$445K 0.28%
16,300
+8,100
+99% +$199K
AG icon
29
First Majestic Silver
AG
$9.07B
$434K 0.27%
33,000
– –
SILV
30
DELISTED
SilverCrest Metals Inc. Common Shares
SILV
$428K 0.27%
48,000
+6,000
+14% +$50.6K
BTAI icon
31
BioXcel Therapeutics
BTAI
$27.8M
$418K 0.26%
1,250
– –
MRTX
32
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$411K 0.26%
+5,000
New +$511K
EQX icon
33
Equinox Gold
EQX
$13.5B
$376K 0.24%
45,500
– –
MAG
34
DELISTED
MAG Silver
MAG
$352K 0.22%
21,750
+4,450
+26% +$70.8K
CNTX icon
35
Context Therapeutics
CNTX
$44.5M
$303K 0.19%
+139,520
New +$293K
SNGX icon
36
Soligenix
SNGX
$5.81M
$198K 0.12%
1,133
-688
-38% -$111K
ANVS icon
37
Annovis Bio
ANVS
$80M
$190K 0.12%
14,210
– –
ORMP icon
38
Oramed Pharmaceuticals
ORMP
$179M
$173K 0.11%
+20,000
New +$205K
ELTX icon
39
Elicio Therapeutics
ELTX
$83.8M
$127K 0.08%
6,000
– –
AGTC
40
DELISTED
Applied Genetic Technologies Corporation
AGTC
$107K 0.07%
100,000
– –
KL
41
DELISTED
Kirkland Lake Gold Ltd Ordinary
KL
– –
-10,750
Closed -$451K
1
2

Similar funds

FBC
Fairfield, Bush & Co Darien, Connecticut $180M AUM 39.51% 1-Year Est. Return
AIC
Aurora Investment Counsel Atlanta, Georgia $180M AUM 0.3% 1-Year Est. Return
AG
Amiral Gestion Paris, France $180M AUM 9.43% 1-Year Est. Return
PCA
Prospect Capital Advisors Sausalito, California $180M AUM 60.99% 1-Year Est. Return
HIC
Hamrick Investment Counsel Seattle, Washington $180M AUM
FFA
Frazier Financial Advisors Columbus, Ohio $181M AUM 11.16% 1-Year Est. Return
V
ViaWealth Leawood, Kansas $180M AUM 20.16% 1-Year Est. Return
RVM
Robinson Value Management San Antonio, Texas $180M AUM 24.17% 1-Year Est. Return

Knoll Capital Management's Q1 2022 Portfolio in Review

As of Q1 2022, Knoll Capital Management held 43 positions worth $159M, down 12% from $182M the previous quarter. Its ten largest holdings account for 87% of the portfolio.

Knoll Capital Management's Q1 2022 filing shows 5 new, 6 increased, 3 reduced and 2 closed positions. Its largest new stake was Anavex Life Sciences: 210,789 shares worth $2.6M. The largest sale was Blackstone, an estimated $976K.

By sector, the portfolio is most concentrated in Healthcare at 86% of assets, up from 86% a quarter earlier, followed by Materials and Technology.

  • Knoll Capital Management's largest Q1 2022 buy was Anavex Life Sciences: 210,789 shares worth $2.6M.
  • Knoll Capital Management added most to Biohaven Pharmaceutical Holding Company Ltd. in Q1 2022, an estimated $499K increase.
  • Knoll Capital Management's biggest Q1 2022 reduction was Blackstone, cutting an estimated $976K.
  • Knoll Capital Management fully exited Kirkland Lake Gold Ltd Ordinary in Q1 2022, selling an estimated $451K.
  • Knoll Capital Management's ten largest holdings make up 87% of its $159M portfolio in Q1 2022.
  • Knoll Capital Management opened 5 new positions and closed 2 in Q1 2022.
  • Knoll Capital Management's portfolio value fell 12% quarter-over-quarter to $159M.

Based on Knoll Capital Management's 13F filing for Q1 2022, filed 16 May 2022.